News
25 Nov 2025
Dr. Reddy’s Denosumab Biosimilar AVT03 Secures European Commission Approval for Treatment of Osteoporosis and Cancer-Related Bone Disease
Dr. Reddy’s Laboratories has announced that the European Commission (EC) has granted marketing authorization for AVT03, a biosimilar of Amgen’s…
